GlassScriptPhysician profile
James Fercilien
NPI 1942772777
$1,744.09
in general payments reported to CMS, 2019-2025
20 companies · $525 in 2025
The $525 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $448 · 2022: $320 · 2023: $296 · 2024: $155 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $976.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $975.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $405.43 | 2021-2022 | |
| Axsome Therapeutics, INC. | $187.25 | 2023-2025 | Auvelity |
| Medtronic, INC. | $181.10 | 2021-2025 | Endurant Iis, Venaseal |
| Eisai INC. | $122.45 | 2021 | |
| Boston Scientific Corporation | $119.15 | 2022-2025 | Varithena Administration Pack |
| Alkermes, INC. | $116.89 | 2023 | Aristada, Aristada Initio |
| Neurocrine Biosciences, INC. | $115.96 | 2025 | |
| Mimedx Group, INC. | $98.50 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $83.87 | 2021 | |
| W. L. Gore & Associates, INC. | $81.58 | 2021-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Excluder Aaa Endoprosthesis |
| Jazz Pharmaceuticals INC. | $38.62 | 2021-2022 | |
| Inspiremd LTD | $33.49 | 2025 | Cguard Prime Carotid Stent System |
| Silk Road Medical, INC. | $28.20 | 2022-2023 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Tactile Systems Technology INC | $23.88 | 2022 | |
| Endologix LLC | $23.48 | 2023 | Alto Abdominal Stent Graft System |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mozarc Medical US LLC | $18.15 | 2023 | Palindrome |
| Noven Therapeutics, LLC | $17.48 | 2021 | |
| Smith+Nephew, INC. | $17.28 | 2023 | Grafix, Stravix |
| Shockwave Medical, INC | $16.63 | 2025 | |
| Baxter Healthcare | $14.70 | 2023 | Floseal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Fercilien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.